We report on the analysis of a murine anaplastic lymphoid cell line TS1G6, established recently by interleukin (IL)-9 transfection. TS1G6 revealed a highly characteristic pattern of large anaplastic cells with mononuclear, binuclear, or multinuclear cells resembling Hodgkin (H) or Sternberg-Reed (SR) cells. This cell line is tumorigenous after injection of as few as 10(4) lymphoma cells into nude or immunocompetent C57Bl/6 mice and leads to death from progressive disease of all treated animals within a few weeks. The histological analysis of these tumors revealed a diffuse large cell malignant lymphoma that is morphologically almost identical to human anaplastic large cell lymphoma (ALCL). The lymphoma cells did not show overexpression of the anaplastic lymphoma kinase (ALK) gene, which is found in about 50% of the cases of human ALCL. Thus, this model may be an animal model for an important subset of human ALCL. The cytokine profile, which is of the T helper 2 type, showed strong parallels to the human lymphoma counterpart. Mice suffering from such lymphomas could not be cured with a regimen using high dose cyclophosphamide similar to many ALCL patients. Such an animal model for ALCL has not yet been recognized, but may provide the basis for investigating new antitumor immunotherapies in a fully immunocompetent host.
Ausubel I, Frederick M and. 1999 Preparation and analysis of RNA. (In: Current Protocols in Molecular Biology) (vol 1) New York: John Wiley and Sons 4.0.1–4.10.11.
Barbey Sylvette, Gogusev Jean, Mouly Héléne, Le Pelletier Odile, Smith Wandy, Richard Stephane, Soulie Joëlle, Nezelof Christian, Del cell line: A “malignant histiocytosis” CD30 + T(5;6)(Q35;P21) cell line, 10.1002/ijc.2910450329
CHOMZYNSKI P, Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction, 10.1006/abio.1987.9999
Del Prete G., CD30-mediated signaling promotes the development of human T helper type 2-like T cells, 10.1084/jem.182.6.1655
Dick John E., Lapidot Tsvee, Pflumio Francoise, Transplantation of Normal and Leukemic Human Bone Marrow into Immune-Deficient Mice: Development of Animal Models for Human Hematopoiesis, 10.1111/j.1600-065x.1991.tb00614.x
Dirks WG, Leukemia, 10, 142 (1996)
Drexler HG, Hum Cell, 5, 42 (1992)
Drexler Hans G., Recent Results on the Biology of Hodgkin and Reed-Sternberg cells: II. Continuous Cell Lines, 10.3109/10428199309148499
Falini B, Blood, 93, 2697 (1999)
Fiorentino D. F., Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones, 10.1084/jem.170.6.2081
Gascoyne RD, Blood, 93, 3913 (1999)
Hamann D, J Immunol, 156, 1387 (1996)
Harris NL, Blood, 84, 1361 (1994)
Iwahara Toshinori, Fujimoto Jiro, Wen Duanzhi, Cupples Rod, Bucay Nathan, Arakawa Tsutomu, Mori Shigeo, Ratzkin Barry, Yamamoto Tadashi, Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system, 10.1038/sj.onc.1200849
Kapp Ursula, Wolf Jürgen, Kalle Christof v., Stein Harald, Fonatsch Christa, Schell-Frederick Elizabeth, Diehl Volker, Recent efforts to establish an in vivo model as a new experimental tool in the study of Hodgkin's disease, 10.1016/0959-8049(92)90531-6
Kinney Marsha C., Collins Robert D., Greer John P., Whitlock James A., Sioutos Nick, Kadin Marshall E., A Small-Cell-Predominant Variant of Primary Ki-1 (CD30)+ T-Cell Lymphoma : , 10.1097/00000478-199309000-00001
Kuefer MU, Blood, 90, 2901 (1997)
Lennert K, Feller AC and. 1992 Histopathology of non-Hodgkin lymphomas: (based on the updated Kiel classification (2nd ed) Springer-Verlag, Berlin 229–244.
Louahed J, J Immunol, 154, 5061 (1995)
McCune J, Kaneshima H, Krowka J, Namikawa R, Outzen H, Peault B, Rabin L, Shih C C, Yee E, The SCID-hu Mouse: A Small Animal Model for HIV Infection and Pathogenesis, 10.1146/annurev.iy.09.040191.002151
Merz H, Am J Pathol, 139, 1173 (1991a)
Merz H, Blood, 78, 1311 (1991b)
Mosier Donald E., Adoptive Transfer of Human Lymphoid Cells to Severely Immunodeficient Mice: Models for Normal Human Immune Function, Autoimmunity, Lymphomagenesis, and AIDS, Advances in Immunology (1991) ISBN:9780120224500 p.303-325, 10.1016/s0065-2776(08)60828-7
Pasqualucci L, Blood, 85, 2139 (1995)
Purtilo David T., Falk Kerstin, Pirruccello Samuel J., Nakamine Hirokazu, Kleveland Kimberly, Davis Jack R., Okano Motohiko, Taguchi Yuichi, Sanger Warren G., Beisel Kirk W., Scid mouse model of epstein-barr virus-induced lymphomagenesis of immunodeficient humans, 10.1002/ijc.2910470407
Renauld J.‐C, Houssiau F., Louahed J., Vink A., Snick J. Van, Uyttenhove C., Interleukin-9, Advances in Immunology Volume 54 (1993) ISBN:9780120224548 p.79-97, 10.1016/s0065-2776(08)60533-7
Terenzi Adelmo, Bolognesi Andrea, Pasqualucci Laura, Flenghi Leonardo, Pileri Stefano, Stein Harald, Kadin Marshall, Bigerna Barbara, Polito Letizia, Tazzari Pier Luigi, Martelli Massimo F., Stirpe Fiorenzo, Falini Brunangelo, Anti-CD30 (BER-H2) immunotoxins containing the type-1 ribosome-inactivating proteins momordin and PAP-S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30+tumour cellsin vitroand in SCID mice, 10.1046/j.1365-2141.1995.404942.x
Tian ZG, Cancer Res, 55, 5335 (1995)
Uyttenhove C., Autonomous growth and tumorigenicity induced by P40/interleukin 9 cDNA transfection of a mouse P40-dependent T cell line, 10.1084/jem.173.2.519
Bibliographic reference
Bittner, C ; Feller, A C ; Renauld, Jean-Christophe ; Lange, K ; Pietrzik, R ; et. al. An animal model for anaplastic large cell lymphoma in the immunocompetent syngeneic C57Bl/6 mouse.. In: Laboratory investigation; a journal of technical methods and pathology, Vol. 80, no. 10, p. 1523-31 (2000)